相关实验视频
Updated: Jan 23, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
86.2K
在CKD中导航贫血治疗:低氧诱导因素激活剂的作用
Volker H Haase1, Nadiesda A Costa2, Mark J Koury3
1Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, TN, 37232; Medical Service, Dept. of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, 37212; Research Service, Dept. of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, 37212.
概括
新的口服贫血药物,低氧诱导因子-酸酶抑制剂 (HIF-PHI),在慢性病 (CKD) 中有效管理血红蛋白. 它们可以替代红色形成刺激剂 (ESA),但需要在非透析的慢性病患者中进一步评估其安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 慢性病 (CKD) 中的贫血带来了临床挑战,推动了超越红色素形成刺激剂 (ESA) 的新型治疗方法的需求.
- 现有的ESA存在相关的安全问题,需要替代治疗策略.
研究的目的:
- 审查低氧诱导因子-基酶抑制剂 (HIF-PHI) 对慢性瘤贫血的作用机制和临床影响.
- 与ESA相比,评估HIF-PHI的安全概况,重点关注心血管风险.
- 讨论HIF-PHI对临床实践的潜在影响,包括对移植患者的使用.
主要方法:
- 对CKD贫血中HIF-PHI和ESAs现有文献的审查.
- 分析作用机制,红色素质效应和安全数据.
- 在有效性和安全性问题上对HIF-PHI和ESA进行比较评估.
主要成果:
- HIF-PHI是有效的口服药物,用于增加和维持慢性病患者的血红蛋白水平.
- 高基基胺刺激内源性红色素的产生,增强铁的新陈代谢.
- 心血管安全问题限制了一些HIF-PHI在非透析CKD患者的使用.
结论:
- 高高血阻尼剂 (HIF-PHI) 是一种新型的口服药物,用于治疗慢性脏病的贫血.
- 对心血管安全的进一步调查对于在CKD中更广泛的HIF-PHI应用至关重要.
- 高高度PHI可能为ESA提供一种有价值的替代品,并且在移植接受者中具有潜在的应用.
相关概念视频
01:28Role of Hematopoietic Growth Factors
3.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.2K
01:17Factors Affecting Activity Coefficient
1.5K
The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size.
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
1.5K
01:23Hypoxia
2.0K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.0K
02:16Transcription Factors
82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
00:59Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
02:35Transcription Elongation Factors
13.5K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K